Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells

Clinical Immunology

Volumn 127, Issue 2, 2008, Pages 130-137

  Tian, Chaorui ^a   Yuan, Xueli ^a   Bagley, Jessamyn ^a   Blazar, Bruce R ^b   Sayegh, Mohamed H ^a   Iacomini, John ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Cancer Center   (United States)

Author keywords

Negative selection; Non myeloablative conditioning; T cells; Tolerance; Transplantation

Indexed keywords

ALLOANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; RAPAMYCIN;

ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CBA MOUSE; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; NONMYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; SKIN ALLOGRAFT; T LYMPHOCYTE; TRANSGENIC MOUSE; TRANSPLANTATION TOLERANCE; WHOLE BODY RADIATION;

ADOPTIVE TRANSFER; ANIMALS; CHIMERISM; FEMALE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; ISOANTIGENS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, TRANSGENIC; SIROLIMUS; SKIN TRANSPLANTATION; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; WHOLE-BODY IRRADIATION;

EID: 41549092810     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.01.005     Document Type: Article

References (38)

1. Owen R.D. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 102 (1945) 400-401
2. Billingham R.E., Brent L., and Medawar P.B. Activity acquired tolerance of foreign cells. Nature 172 (1953) 603-606
3. Slavin S., Strober S., Fuks Z., and Kaplan H.S. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts. J. Exp. Med. 146 (1977) 34-48
4. Ildstad S.T., and Sachs D.H. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307 (1984) 168-170
5. Wekerle T., and Sykes M. Mixed chimerism and transplantation tolerance. Annu. Rev. Med. 52 (2001) 353-370
6. Daly A., McAfee S., Dey B., Colby C., Schulte L., Yeap B., Sackstein R., Tarbell N.J., Sachs D., Sykes M., and Spitzer T.R. Non-myeloablative bone marrow transplantation: infectious complications in 65 recipients of HLA-identical and mismatched transplants. Biol. Blood Marrow Transplant 9 (2003) 373-382
7. Blazar B.R., and Murphy W.J. Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD). Philos. Trans. R. Soc. Lond. B. Biol. Sci. 360 (2005) 1747-1767
8. Parkman R., and Weinberg K.I. Immunological reconstitution following bone marrow transplantation. Immunol. Rev. 157 (1997) 73-78
9. Williams M.A., Adams A.B., Walsh M.B., Shirasugi N., Onami T.M., Pearson T.C., Ahmed R., and Larsen C.P. Primary and secondary immunocompetence in mixed allogeneic chimeras. J. Immunol. 170 (2003) 2382-2389
10. Clift R.A., and Storb R. Histoincompatible bone marrow transplants in humans. Annu. Rev. Immunol. 5 (1987) 43-64
11. Welniak L.A., Blazar B.R., and Murphy W.J. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu. Rev. Immunol. 25 (2007) 139-170
12. Tian C., Bagley J., and Iacomini J. Expression of antigen on mature lymphocytes is required to induce T cell tolerance by gene therapy. J. Immunol. 169 (2002) 3771-3776
13. Tian C., Bagley J., Forman D., and Iacomini J. Induction of central tolerance by mature T cells. J. Immunol. 173 (2004) 7217-7222
14. Tian C., Bagley J., and Iacomini J. Homeostatic expansion permits T cells to re-enter the thymus and deliver antigen in a tolerogenic fashion. Am. J. Transplant. 7 (2007) 1934-1941
15. Yeoman H., and Mellor A.L. Tolerance and MHC restriction in transgenic mice expressing a MHC class I gene in erythroid cells. Int. Immunol. 4 (1992) 59-65
16. Sponaas A.M., Tomlinson P.D., Antoniou J., Auphan N., Langlet C., Malissen B., Schmitt-Verhulst A.M., and Mellor A.L. Induction of tolerance to self MHC class I molecules expressed under the control of milk protein or beta-globin gene promoters. Int. Immunol 6 (1994) 277-287
17. Couez D., Malissen M., Buferne M., Schmitt-Verhulst A.M., and Malissen B. Each of the two productive T cell receptor alpha-gene rearrangements found in both the A10 and BM 3.3 T cell clones give rise to an alpha chain which can contribute to the constitution of a surface-expressed alpha beta dimer. Int. Immunol. 3 (1991) 719-729
18. Noelle R.J., Roy M., Shepherd D.M., Stamenkovic I., Ledbetter J.A., and Aruffo A. A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6550-6554
19. Bagley J., Sawada T., Wu Y., and Iacomini J. A critical role for interleukin 4 in activating alloreactive CD4 T cells. Nat. Immunol. (2000) 257-261
20. Sawada T., Wu Y., Sachs D.H., and Iacomini J. CD4+ T cells are able to reject class I disparate allografts. Transplantation 64 (1997) 335-340
21. Friedman T., Shimizu A., Smith R.N., Colvin R.B., Seebach J.D., Sachs D.H., and Iacomini J. Human CD4+ T cells mediate rejection of porcine xenografts. J. Immunol. 162 (1999) 5256-5262
22. Storek J., Gooley T., Siadak M., Bensinger W.I., Maloney D.G., Chauncey T.R., Flowers M., Sullivan K.M., Witherspoon R.P., Rowley S.D., Hansen J.A., Storb R., and Appelbaum F.R. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90 (1997) 4705-4709
23. Knechtle S.J. Knowledge about transplantation tolerance gained in primates. Curr. Opin. Immunol. 12 (2000) 552-556.
24. Fehr T., and Sykes M. Tolerance induction in clinical transplantation. Transpl. Immunol. 13 (2004) 117-130
25. Toh H.C., Spitzer T.R., Preffer F., Alexander S.I., McAfee S., Dombkowski D., Clark J.S., Colby C., Saidman S., Sackstein R., and Sykes M. Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving non-myeloablative conditioning and a haploidentical related allogeneic bone marrow transplant. Cytokines. Cell. Mol. Ther. 7 (2002) 43-47
26. Dey B.R., McAfee S., Colby C., Cieply K., Caron M., Saidman S., Preffer F., Shaffer J., Tarbell N., Sackstein R., Sachs D., Sykes M., and Spitzer T.R. Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation. Br. J. Haematol. 128 (2005) 351-359
27. Anderson C.C., and Matzinger P. Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat. Med. 7 (2001) 80-87
28. Taylor P.A., Lees C.J., Wilson J.M., Ehrhardt M.J., Campbell M.T., Noelle R.J., and Blazar B.R. Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under non-myeloablative conditions. Blood 100 (2002) 3400-3407
29. Forman D., Kang E.S., Tian C., Paez-Cortez J., and Iacomini J. Induction of alloreactive CD4 T cell tolerance in molecular chimeras: a possible role for regulatory T Cells. J. Immunol 176 (2006) 3410-3416
30. Wise M., Zelenika D., Bemelman F., Latinne D., Bazin H., Cobbold S., and Waldmann H. CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts. Eur. J. Immunol. 29 (1999) 156-167
31. Jones N.D., Turvey S.E., Van Maurik A., Hara M., Kingsley C.I., Smith C.H., Mellor A.L., Morris P.J., and Wood K.J. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J. Immunol. 166 (2001) 2824-2830
32. Markees T.G., Phillips N.E., Noelle R.J., Shultz L.D., Mordes J.P., Greiner D.L., and Rossini A.A. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 64 (1997) 329
33. Seung E., Mordes J.P., Rossini A.A., and Greiner D.L. Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning. J. Clin. Invest. 112 (2003) 795-808
34. Holling T.M., van der Stoep N., Quinten E., and van den Elsen P.J. Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III. J. Immunol. 168 (2002) 763-770
35. Lanzavecchia A., Roosnek E., Gregory T., Berman P., and Abrignani S. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature 334 (1988) 530-532
36. Siliciano R.F., Lawton T., Knall C., Karr R.W., Berman P., Gregory T., and Reinherz E.L. Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: Effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell 54 (1988) 561-575
37. Takemoto S., Port F.K., Claas F.H., and Duquesnoy R.J. HLA matching for kidney transplantation. Hum. Immunol. 65 (2004) 1489-1505
38. Opelz G., Wujciak T., Dohler B., Scherer S., and Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev. Immunogenet 1 (1999) 334-342